Asklepios Kliniken GmbH: Healthcare group continues profitable growth in the first half of 2015
Asklepios continued to grow in line with its targets in the first half of 2015. Asklepios again saw increases in both revenue and operating earnings, expanding its position as one of the leading private clinic operators in Germany.
Between January and June 2015, Asklepios treated 1,105,516 patients, which corresponds to an increase of 1.6% as against the figure for the same period of the previous year and, at the same time, is the principal revenue driver. Asklepios generated revenue of EUR 1,541.1 million in the first six months, an increase of 2.0% year-on-year (H1 2014: EUR 1,510.8 million). The capacity utilisation rate was also up slightly at 84.0% with the number of beds between January and June remaining constant compared to the previous year (H1 2014: 83.7%).
Dr Ulrich Wandschneider, CEO of Asklepios Kliniken GmbH, commented: “Our facilities again experienced a rising number of patients in the first half of the year. Combined with an improved cost structure, we also increased our operating earnings significantly in the first half of the year. Our strategy, which is geared to medical quality, innovation and social responsibility, is a persuasive one. Asklepios has spent years working to achieve this show of trust. Asklepios is excellently positioned throughout Germany for 2015 as a whole and the future.”
Further equity increase – investments from own funds at new high
The Group’s sound balance sheet structures continued to improve in the past financial year. For example, the equity of Asklepios Kliniken GmbH exceeded the billion mark for the first time, amounting to EUR 1,001.7 million (31 December 2013: EUR 926.3 million). With total assets up 3.9% at EUR 2,863.4 million (31 December 2013: EUR 2,755.0 million), the equity ratio was 35.0% (31 December 2013: 33.6%).
Stephan Leonhard, Vice-Chairman of the Group management team and CFO, commented: “In 2014, Asklepios again benefited from its position as an integrated healthcare company and is clearly at the upper end of its forecast with the targets achieved. We again found out that financial solidity and outstanding medical quality are mutually dependent in the hospital sector. The Asklepios Group is in rude financial health and continues to use its strength for high internally financed investments in hospitals throughout Germany.”
In total, the Group invested EUR 242.7 million in intangible assets and property, plant and equipment in the 2014 financial year. Investments from own funds (total investments less public subsidies) reached a new high of EUR 160.7 million, while the subsidy ratio fell to just 33.8%.
The success story continues
Group management is confident that Asklepios will continue to grow qualitatively and quantitatively in 2015, the year of its 30th anniversary, and build on its position as Europe’s leading family-owned business in the hospital sector. In the forecast for the 2015 financial year, Asklepios assumes continued organic revenue growth of approximately 2% to 4% and a further sustained increase in the operating result. The 2014 annual report will be published in the Investor Relations section of the Asklepios website (www.asklepios.com) during the course of today.
About Asklepios
The Asklepios Kliniken GmbH healthcare group is among the leading private operators of hospitals and healthcare facilities in Germany. The clinic group pursues a responsible, sustainable growth strategy that is geared towards high quality and innovative strength. On this basis, Asklepios has developed dynamically since it was founded 30 years ago. The Group currently has around 150 healthcare facilities nationwide and employs more than 45,000 people. In the last financial year 2014, approximately 2.2 million patients were treated in Asklepios Group facilities.
Talk to us
Mirjam Constantin
Head of Group Reporting (Financial & ESG) | Manager Investor Relations
- type a message
- +49 61 74 90 11 66
- +49 61 74 90 11 10
Rune Hoffmann
Head of Corporate Communications & Marketing, Company Spokesperson